BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20721888)

  • 1. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
    Parajuli R; Altman J; Kuzel T; Perdekamp M; Tallman M
    Am J Hematol; 2010 Oct; 85(10):829. PubMed ID: 20721888
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy induced esophageal stricture.
    Kassam A; Mandel K
    Pediatr Blood Cancer; 2009 Apr; 52(4):551. PubMed ID: 19061235
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
    Okamoto T; Okada M; Wakae T; Mori A; Takatsuka H; Kakishita E
    Int J Hematol; 2002 Jan; 75(1):107-8. PubMed ID: 11843282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia].
    Sakamaki H; Nakamura S; Maruyama Y; Nagata K; Yahara Y; Onozawa Y
    Rinsho Ketsueki; 1989 Nov; 30(11):1975-81. PubMed ID: 2691721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Petti MC; Mandelli F
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
    Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
    Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).
    Klein SK; Biemond BJ; van Oers MH
    Ann Hematol; 2007 Dec; 86(12):917-8. PubMed ID: 17619879
    [No Abstract]   [Full Text] [Related]  

  • 10. Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
    Tang YL; Chia WK; Yap EC; Julia MI; Leong CF; Salwati S; Wong CL
    Malays J Pathol; 2016 Dec; 38(3):315-319. PubMed ID: 28028303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.
    Cheuk DK; Shek TW; Chan GC; Lau YL; Ha SY; Chiang AK
    Pediatr Blood Cancer; 2008 Mar; 50(3):636-9. PubMed ID: 16865683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.
    Huang FS; Zwerdling T; Stern LE; Ballard ET; Warner BW
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):609-11. PubMed ID: 11902306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon may reduce minimal residual disease of acute promyelocytic leukemia.
    Egyed M; Rumi G; Boros B; Páldi-Haris P; Földi J
    Leukemia; 2000 Jun; 14(6):1153. PubMed ID: 10865982
    [No Abstract]   [Full Text] [Related]  

  • 14. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
    Innes A; May PC; Pavlů J; Bain BJ
    Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.
    Keane C; Mollee P; Marlton P; Gill D
    Ann Hematol; 2011 Mar; 90(3):359-60. PubMed ID: 20607537
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
    Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
    [No Abstract]   [Full Text] [Related]  

  • 17. Updates on the treatment of acute promyelocytic leukemia.
    Tallman MS
    Clin Adv Hematol Oncol; 2010 Feb; 8(2):89-90. PubMed ID: 20386527
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapeutic results in acute myeloid leukemias in elderly patients].
    Parovichnikova EN; Savchenko VG; Isaev VG; Tikhonova LIu; Sarycheva TG; Kulikov SM
    Ter Arkh; 1992; 64(8):87-9. PubMed ID: 1440406
    [No Abstract]   [Full Text] [Related]  

  • 19. Central nervous system relapse in acute promyelocytic leukemia.
    Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
    Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe myopericarditis following induction therapy with idarubicin and transretinoic acid in a patient with acute promyelocytic leukemia.
    Carcelero San Martín E; Riu Viladoms G; Creus Baró N
    Med Clin (Barc); 2018 Jun; 150(12):492-493. PubMed ID: 29196036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.